Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Immune checkpoint and angiogenic inhibitors for the treatment of hepatocellular carcinoma: It takes two to tangle
Caecilia Sukowati; Loraine Kay D. Cabral; Claudio Tiribelli;
Ann Hepatol. 2022;27:
Clinical treatment of cholangiocarcinoma: an updated comprehensive review
Alessandra Elvevi; Alice Laffusa; Miki Scaravaglio; Roberta Elisa Rossi; Raffaella Longarini; Anna Maria Stagno; Laura Cristoferi; Antonio Ciaccio; Diego Luigi Cortinovis; Pietro Invernizzi; Sara Massironi;
Ann Hepatol. 2022;27:
Camrelizumab combined with transcatheter arterial chemoembolization and sorafenib or lenvatinib for unresectable hepatocellular carcinoma: A multicenter, retrospective study
Xiumei Jiang; Pan Wang; Ke Su; Han Li; Hao Chi; Fei Wang; Yu Liu; Ke Xu;
10.1016/j.aohep.2024.101578